美国ATP 检测市场规模、份额和趋势分析报告：按类型、应用、最终用途和细分市场预测，2025 年至 2033 年

美国ATP 检测市场规模与趋势

预计 2024 年美国ATP 检测市场价值将达到 11 亿美元，到 2033 年复合年增长率将达到约 3.87%。

该市场的主要驱动力在于药物研发、临床诊断、环境监测和食品安全应用领域对快速可靠检测方法日益增长的需求。在药物研发和临床研究中，ATP 检测在细胞活力和细胞毒性测试中发挥关键作用；而在环境检测和食品品管， ATP 检测则支援污染检测和卫生检验。这些领域对高效能即时分析日益增长的需求，持续推动着基于发光的自动化 ATP 平台的普及。

此外，不断增长的检测样本量推动了更先进的 ATP 检测系统的采用，这些系统支援更快、更有效率的处理。改进的样本製备、测量和管理使实验室能够更有效率地工作并减少延误。这些变化使药物检测和污染检测等对时间和准确性至关重要的领域受益。 2024 年 12 月，Hygena 收购了 Nexcor Food Safety Technologies Inc.，增强了其 ATP 和环境监测产品线，并满足了对快速、可靠检测解决方案日益增长的需求。

此外，美国ATP检测市场正经历着向整合自动化检测系统的显着转变，尤其是在製药和食品品管。这些平台旨在透过将快速检测功能与数位记录保存和云端基础分析相结合，简化污染监测和法规遵循。对标准化、可追溯和高通量工作流程日益增长的需求，正在推动各个细分市场的采用。这种转变与强调即时数据、业务效率和遵守不断变化的法规要求的更广泛趋势相一致，正在推动美国ATP检测市场的持续扩张。

此外，医疗保健、食品製造和环境领域对生物安全和品质保证标准的日益重视，也推动了对 ATP 检测技术的持续投资。实验室和生产设施越来越注重降低污染风险，并符合美国食品药物管理局 (FDA) 和美国农业部 (USDA) 等机构制定的监管准则。这推动了 ATP检测法融入品管框架，尤其是在环境监测和常规筛检工作流程中。随着各机构越来越重视合规性和效率，美国ATP 检测市场预计将受益于快速、准确且可扩展的检测解决方案的稳定、跨领域需求。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国ATP 检测市场变数、趋势与范围

• 市场体系展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 美国ATP检测市场分析工具
  • 产业分析—波特五力分析
  • PESTEL分析

第四章。美国ATP 检测市场类型、估计与趋势分析

• 2024年和2033年的类型市场占有率
• 细分仪表板
• 美国ATP检测市场展望（按类型）
• 2021年至2033年市场规模、预测与趋势分析
  • 发光ATP测定法
  • 酶促ATP测定
  • 生物发光共振能量转移（BRET）ATP测定
  • 基于细胞的ATP测定
  • 其他的

第五章美国ATP 检测市场：应用、估算与趋势分析

• 2024 年和 2033 年应用市场占有率
• 细分仪表板
• 美国ATP 检测市场：应用前景
• 2021年至2033年市场规模、预测与趋势分析
  • 药物研发
  • 临床诊断
  • 环境检查
  • 食品安全与品质检验
  • 其他的

第六章美国ATP 检测市场：依最终用途的估算与趋势分析

• 2024年和2033年的最终用途市场占有率
• 细分仪表板
• 美国ATP检测市场：最终用途展望
• 2021年至2033年市场规模、预测与趋势分析
  • 製药和生物技术公司
  • 学术研究机构
  • 医院和诊断实验室

第七章 竞争态势

• 主要市场参与企业的近期趋势和影响分析
• 公司/竞争对手分类
• 供应商格局
  • 主要经销商和通路合作伙伴名单
  • 2024年主要企业市场占有率分析
  • Thermo Fisher Scientific
  • Promega Corporation
  • PerkinElmer Inc.
  • Becton, Dickinson and Company（BD）
  • Lonza Group Ltd.
  • Danaher Corporation
  • Abcam plc
  • Quest Diagnostics Incorporated
  • Biomerieux SA
  • 3M Company

U.S. ATP Assays Market Size & Trends:

The U.S. ATP assays market size was estimated at USD 1.10 billion in 2024 and is projected to register a CAGR of around 3.87% through 2033. The market is primarily driven by increasing demand for rapid, reliable testing methods across drug discovery, clinical diagnostics, environmental monitoring, and food safety applications. In drug development and clinical research, ATP assays play a key role in cell viability and cytotoxicity studies, while their use in environmental testing and food quality control supports contamination detection and hygiene verification. The growing need for high throughput, real time analysis across these sectors continues to support adoption of automated, luminescence based ATP platforms.

In addition, the rising number of samples being tested has led to the adoption of more advanced ATP assay systems that support faster and more efficient processing. Improvements in preparing, measuring, and managing samples have helped laboratories work more effectively and reduce delays. These changes benefit areas such as drug testing and contamination detection, where time and accuracy matter. In December 2024, Hygiena acquired Nexcor Food Safety Technologies Inc., strengthening its range of ATP and environmental monitoring products and supporting the growing demand for quick, reliable testing solutions.

Moreover, the U.S. ATP Assays market is witnessing a notable shift toward integrated and automated detection systems, particularly in pharmaceutical manufacturing and food quality control. These platforms are designed to streamline contamination monitoring and regulatory compliance by combining rapid testing capabilities with digital record-keeping and cloud-based analytics. The growing need for standardized, traceable, and high-throughput workflows drives adoption across various sectors. This shift aligns with broader trends emphasizing real-time data, operational efficiency, and adherence to evolving regulatory requirements, reinforcing the continued expansion of the U.S. ATP Assays market.

Furthermore, growing awareness of biosafety and quality assurance standards across healthcare, food production, and environmental sectors supports sustained investment in ATP assay technologies. Laboratories and production facilities are placing increased emphasis on minimizing contamination risks and meeting regulatory guidelines set by agencies such as the FDA and USDA. This has led to greater integration of ATP assays within quality control frameworks, particularly within environmental monitoring and routine screening workflows. With organizations prioritizing compliance and efficiency, the U.S. ATP Assays market is expected to benefit from stable, cross-sector demand for fast, accurate, and scalable testing solutions.

U.S. ATP Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. ATP assays market on the test type,application, and end use:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Luminometric ATP Assays
• Enzymatic ATP Assays
• Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
• Cell-based ATP Assays
• Others
• Application Outlook (Revenue, USD Million, 2021- 2033)
• Drug Discovery and Development
• Clinical Diagnostics
• Environmental Testing
• Food Safety and Quality Testing
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospital and Diagnostics Laboratories

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in U.S.
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. ATP Assays market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising emphasis on cell-based research in drug development
    • 3.2.1.2. Increased adoption in food and beverage industry for hygiene monitoring
    • 3.2.1.3. Expansion of biomanufacturing and bioprocess monitoring
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited specificity in complex biological samples
    • 3.2.2.2. Availability of alternative assay techniques
• 3.3. U.S. ATP Assays market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. ATP Assays market: Type Estimates & Trend Analysis

• 4.1. Type Market Share, 2024 & 2033
• 4.2. Segment Dashboard
• 4.3. U.S. ATP Assays market by Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.4.1. Luminometric ATP Assays
    • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Enzymatic ATP Assays
    • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
    • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.4. Cell-based ATP Assays
    • 4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. ATP Assays market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2033
• 5.2. Segment Dashboard
• 5.3. U.S. ATP Assays market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.4.1. Drug Discovery and Development
    • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Clinical Diagnostics
    • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Environmental Testing
    • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.4. Food Safety and Quality Testing
    • 5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.5. Others
    • 5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. ATP Assays market: End use Estimates & Trend Analysis

• 6.1. End use Market Share, 2024 & 2033
• 6.2. Segment Dashboard
• 6.3. U.S. ATP Assays market by End use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.4.1. Pharmaceutical and Biotechnology Companies
    • 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.2. Academic and Research Institutes
    • 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.4.3. Hospital and Diagnostics Laboratories
    • 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Thermo Fisher Scientific
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Promega Corporation
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. PerkinElmer Inc.
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Becton, Dickinson and Company (BD)
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Lonza Group Ltd.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Danaher Corporation
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Abcam plc
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Quest Diagnostics Incorporated
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Biomerieux SA
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. 3M Company
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviation
• Table 2 U.S. ATP assays market, by type, 2021 - 2033 (USD Million)
• Table 3 U.S. ATP assays market, by application, 2021 - 2033 (USD Million)
• Table 4 U.S. ATP assays market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in U.S.
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. ATP Assays market: market outlook
• Fig. 10 U.S. ATP Assays competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 U.S. ATP Assays market driver impact
• Fig. 16 U.S. ATP Assays market restraint impact
• Fig. 17 U.S. ATP Assays market strategic initiatives analysis
• Fig. 18 U.S. ATP Assays market: Type movement analysis
• Fig. 19 U.S. ATP Assays market: Type outlook and key takeaways
• Fig. 20 Luminometric ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 21 Enzymatic ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 22 Bioluminescence Resonance Energy Transfer (BRET) ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 23 Cell-based ATP Assays market estimates and forecast, 2021 - 2033
• Fig. 24 Others market estimates and forecast, 2021 - 2033
• Fig. 25 U.S. ATP Assays market: Application movement Analysis
• Fig. 26 U.S. ATP Assays market: Application outlook and key takeaways
• Fig. 27 Drug Discovery and Development market estimates and forecasts, 2021 - 2033
• Fig. 28 Clinical Diagnostics market estimates and forecasts, 2021 - 2033
• Fig. 29 Environmental Testing market estimates and forecasts, 2021 - 2033
• Fig. 30 Food Safety and Quality Testing market estimates and forecasts, 2021 - 2033
• Fig. 31 Others market estimates and forecasts, 2021 - 2033
• Fig. 32 U.S. ATP Assays market: End use movement analysis
• Fig. 33 U.S. ATP Assays market: End use outlook and key takeaways
• Fig. 34 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2021 - 2033
• Fig. 35 Academic and Research Institutes market estimates and forecasts, 2021 - 2033
• Fig. 36 Hospital and Diagnostics Laboratories market estimates and forecasts, 2021 - 2033
• Fig. 37 U.S. ATP Assays market share and leading players
• Fig. 38 U.S. market share and leading players
• Fig. 39 U.S. market estimates and forecasts, 2021 - 2033
• Fig. 40 Market share of key market players - U.S. ATP Assays market